MA
BHVN icon

MYDA Advisors’s Biohaven BHVN Stock Holding History

MYDA Advisors’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-120,000
Closed -$1.8M – 149
2025
Q3 		$1.8M Buy
+120,000
New +$1.75M 0.39% 68

Other funds holding BHVN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MYDA Advisors's BHVN Position: Q1 2026 in Review

MYDA Advisors reduced its Biohaven (BHVN) stake by 2% in Q1 2026, selling an estimated $274K and leaving 1,225,000 shares worth $10.4M. The position accounts for 1.7% of the portfolio, ranked #13.

MYDA Advisors first reported a position in BHVN in Q1 2023 and has held it in 11 quarters since. The position peaked at $14.1M in Q4 2025. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

  • MYDA Advisors held 1,225,000 shares of Biohaven worth $10.4M as of Q1 2026.
  • MYDA Advisors sold 25,000 Biohaven shares in Q1 2026, an estimated $274K.
  • Biohaven made up 1.7% of MYDA Advisors's portfolio in Q1 2026, its #13 holding.
  • MYDA Advisors first reported a position in Biohaven in Q1 2023 and has held it in 11 quarters since.
  • MYDA Advisors's Biohaven position peaked at $14.1M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on MYDA Advisors's 13F filing for Q1 2026, filed 14 May 2026.